264 related articles for article (PubMed ID: 31148582)
1. Post-diagnostic C-reactive protein and albumin predict survival in Chinese patients with non-small cell lung cancer: a prospective cohort study.
Yang JR; Xu JY; Chen GC; Yu N; Yang J; Zeng DX; Gu MJ; Li DP; Zhang YS; Qin LQ
Sci Rep; 2019 May; 9(1):8143. PubMed ID: 31148582
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of C-reactive protein/albumin ratio on the overall survival of patients with advanced nonsmall cell lung cancers receiving palliative chemotherapy.
Koh YW; Lee HW
Medicine (Baltimore); 2017 May; 96(19):e6848. PubMed ID: 28489774
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
Ni XF; Wu P; Wu CP; Ji M; Wu J; Gu XF; Jiang ZX
Asia Pac J Clin Oncol; 2015 Dec; 11(4):e22-30. PubMed ID: 24889374
[TBL] [Abstract][Full Text] [Related]
4. C-Reactive Protein/Albumin Ratio Is an Independent Prognostic Predictor of Survival in Advanced Cancer Patients Receiving Palliative Care.
Zhang J; Zhang C; Li Q; Zhang J; Gu X; Zhao W; Chen M; Liu M; Zhang Z; Liao X; Cheng W
J Palliat Med; 2019 Dec; 22(12):1536-1545. PubMed ID: 31188054
[No Abstract] [Full Text] [Related]
5. The C-reactive protein/albumin ratio predicts long-term outcomes of patients with operable non-small cell lung cancer.
Zhang F; Ying L; Jin J; Chen K; Zhang N; Wu J; Zhang Y; Su D
Oncotarget; 2017 Jan; 8(5):8835-8842. PubMed ID: 27823974
[TBL] [Abstract][Full Text] [Related]
6. Serum cholinesterase may independently predict prognosis in non-small-cell lung cancer.
Ran H; Ma J; Cai L; Zhou H; Yuan Z; Chen Y; Chang W; Huang Y; Xiao Y
BMC Cancer; 2022 Jan; 22(1):93. PubMed ID: 35062903
[TBL] [Abstract][Full Text] [Related]
7. The C-Reactive Protein/Albumin Ratio Is Useful for Predicting Short-Term Survival in Cancer and Noncancer Patients.
Miyamoto T; Fujitani M; Fukuyama H; Hatanaka S; Koizumi Y; Kawabata A
J Palliat Med; 2019 May; 22(5):532-537. PubMed ID: 30570426
[No Abstract] [Full Text] [Related]
8. Prognostic Impact of Postoperative C-reactive Protein for Non-small Cell Lung Cancer Following Lobectomy.
Shinohara S; Sugaya M; Onitsuka T; Machida K; Matsuo M; Tanaka F
Anticancer Res; 2018 May; 38(5):3193-3198. PubMed ID: 29715162
[TBL] [Abstract][Full Text] [Related]
9. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.
Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M
Ann Surg Oncol; 2015 Mar; 22(3):803-10. PubMed ID: 25190127
[TBL] [Abstract][Full Text] [Related]
10. Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: A comprehensive analysis of systemic inflammatory markers.
Akamine T; Takada K; Toyokawa G; Kinoshita F; Matsubara T; Kozuma Y; Haratake N; Takamori S; Hirai F; Tagawa T; Okamoto T; Yoneshima Y; Okamoto I; Shimokawa M; Oda Y; Nakanishi Y; Maehara Y
Surg Oncol; 2018 Mar; 27(1):88-94. PubMed ID: 29549910
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of pretreatment albumin-to-alkaline phosphatase ratio for overall survival for patients with advanced non-small cell lung cancer.
Zhou S; Jiang W; Wang H; Wei N; Yu Q
Cancer Med; 2020 Sep; 9(17):6268-6280. PubMed ID: 32691996
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J
BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566
[TBL] [Abstract][Full Text] [Related]
13. Combined C-reactive protein and Neutrophil to Lymphocyte ratio use predict survival innon-small-cell lung cancer.
Bacha S; Sghaier A; Habibech S; Cheikhrouhou S; Racil H; Chaouch N; Zaouri B; Chabbou A
Tunis Med; 2017 Dec; 95(12):229-235. PubMed ID: 29878284
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
Koch A; Fohlin H; Sörenson S
J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein is a significant predictor of improved survival in patients with advanced non-small cell lung cancer.
Xiao X; Wang S; Long G
Medicine (Baltimore); 2019 Jun; 98(26):e16238. PubMed ID: 31261584
[TBL] [Abstract][Full Text] [Related]
16. Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals.
Li SQ; Jiang YH; Lin J; Zhang J; Sun F; Gao QF; Zhang L; Chen QG; Wang XZ; Ying HQ
Cancer Med; 2018 Apr; 7(4):1221-1231. PubMed ID: 29533009
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma.
Chen Z; Shao Y; Fan M; Zhuang Q; Wang K; Cao W; Xu X; He X
Int J Clin Exp Pathol; 2015; 8(11):14893-900. PubMed ID: 26823819
[TBL] [Abstract][Full Text] [Related]
18. [The prognostic value of detection of serum C-reactive protein in the patients with stage I lung cancer].
Xu Y; Li Z; Shen-Tu Y
Zhongguo Fei Ai Za Zhi; 2011 May; 14(5):400-3. PubMed ID: 21569644
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of C-reactive protein/albumin ratio and its relationship with survival in dogs with acute pancreatitis.
Gori E; Pierini A; Lippi I; Ceccherini G; Perondi F; Marchetti V
N Z Vet J; 2020 Nov; 68(6):345-348. PubMed ID: 32539626
[No Abstract] [Full Text] [Related]
20. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
Fan J; Yu H; Lv Y; Yin L
Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
